ENTITY
SK Biopharmaceuticals

SK Biopharmaceuticals (326030 KS)

174
Analysis
Health Care • South Korea
SK Biopharmaceuticals Co., Ltd. researches and develops new drugs. The Company develops and markets brain disorders treatment drugs, central nervous system disorders treatment drugs, and other products. SK Biopharmaceuticals markets its products worldwide.
more
•11 Jun 2020 02:55

SK Biopharmaceuticals IPO: Potential Overhang Issue by SK Holdings

First, let me tell you this. The mood seems super hot on the SK Biopharm IPO. The book-building (overseas) is now in progress.And we are already...

Logo
567 Views
Share
•03 Jun 2020 07:57

SK Biopharmaceuticals - Fast Index Entry Possibilities

SK Biopharmaceuticals (BIO SK) could reopen the Korean IPO market with its listing that is expected later this month. With 19.58m shares being...

Logo
713 Views
Share
•27 May 2020 06:56

SK Biopharmaceuticals IPO: Betting on Early Inclusion in KOSPI 200?

When it comes to the local street's investment mood in Korea, I usually visit two news websites. They are Invest Chosun and MoneyToday the Bell....

Logo
635 Views
Share
bullish•SK Inc
•21 May 2020 07:38

SK Holdings: Strong Momentum from SK Biopharm IPO & Updated SoTP Valuation Analysis

SK Holdings (034730 KS)'s share price has been on a tear lately. SK Holdings' share price is up 116% since 19 March, although it is still down 15%...

Logo
352 Views
Share
•21 May 2020 02:49

SK Biopharmaceuticals IPO: Offering Terms & Issues for Consideration

This insight has two parts: 1. offering terms and 2. issues for consideration.Offering termsThis IPO would easily be this year's biggest from...

Logo
434 Views
Share
x